Plenary Sessions at a Glance
Wednesday, January 28 |
|
| 6:00 - 7:15am | Intrathecal Therapies for Chronic Pain: Old Challenges and New Developments (112) Intrathecal drug delivery (IDD) for the management of intractable cancer and non-cancer pain has been available for nearly 30 years. Advantages of IDD include effective pain control, fewer side effects compared with systemic medications, ability to easily adjust dosages, and provide a therapy that is reversible. This course will provide a comprehensive overview of intrathecal therapy including pharmacologic sites of action, emerging therapies including the most current consensus-based treatment algorithm, advances in medication delivery (equipment and programming), as well as potential complications arising from IDD and strategies to minimize their occurrence.
6:00 - 6:05 am
6:05 - 6:25 am
6:25 - 6:45 am
6:45 - 7:05 am
7:05-7:15 am This program is supported by an unrestricted educational grant from Elan Pharmaceuticals, Inc. |
Thursday, January 29 |
|
| 7:00 - 8:00am | Neuroplasticity and Chronic Pain (101) - A Must See Session!!
Norman Doidge, MD |
|
|
Plenary Research Highlights (102)
Intro: Ajay D. Wasan, MD MSc |
|
|
AAPM President's Welcome Address (103) |
|
|
American Medical Association Address: Quality Patient Care (104) |
Friday, January 30 |
|
| 7:15 - 8:15am | The Loneliness of Science in Interventional Pain Medicine (105)
Nikolai Bogduk, MD |
|
|
AAPM Plenary Research Highlights (106)
Intro: Jeffrey Tiede, MD |
|
|
Acupuncture: Historical Perspectives and Emerging Advances in the Treatment of Pain and Addiction (107)
Jisheng Han, MD |
|
|
Recent Advances in Complex Regional Pain Syndrome (113) Objective correlates of CRPS provide utility for diagnostic criteria. Understanding of the small fiber changes that occur change the way we evaluate the syndrome and raise questions about whether there is a difference between CRPS I and CRPS II. Rat models are permitting cellular and molecular investigation. Functional magnetic resonance imaging (fMRI) of the brain of CRPS patients provides insight into the central nature of the syndrome. Ketamine and local anesthetic infusions are being studied on both inpatient and outpatient basis and results will be presented. In recent years the efficacy of spinal cord stimulation for CRPS has been questioned. Relevant literature will be critically reviewed, with the goal of linking some of the pathophysiologic concepts with modern treatment.
Moderator: Joshua P. Prager, MD MS
Objective Correlates in the Diagnosis of CRPS: Small Fiber Changes
CRPS and SCS: Evaluating the Evidence
CRPS and Ketamine: A Look at Recent Protocols This educational program is supported through unrestricted medical education grants from Medtronic, Inc., Boston Scientific and Advanced Neuromodulation Systems, Inc. |
|
|
The Art of Pain Medicine: When Needles and Drugs Don't Work (108)
Moderator: Perry G. Fine, MD - Program Committee Co-Chair Panelists:
Kenneth A. Follett, MD PhD |
Saturday, January 31 |
|
| 8:00 - 8:30am | Plenary Research Highlights (109)
Intro: Leonardo Kapural, MD PhD |
|
|
Pain Medicine in Older Adults: Preparing for a Paradigm Shift (110)
Debra Weiner, MD |
|
|
WAR and PAIN: From Battlefield to Back Home (111)
Chester ‘Trip' Buckenmeier III, MD COL MC USA
R. Norman Harden, MD |
AAPM's award-winning publications are devoted to the advancement of
pain management, education and research.